Lenvatinib Mesylate and Typhoid vi polysaccharide vaccine Intramuscular
Determining the interaction of Lenvatinib Mesylate and Typhoid vi polysaccharide vaccine Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: typhoid vaccine, inactivated
Brand name: Typhim VI
Synonyms: Typhoid vaccine (inactivated), injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Tysabri
- Lenvatinib Mesylate-Tyvaso
- Lenvatinib Mesylate-Tyzeka
- Lenvatinib Mesylate-Tyzine
- Typhoid vi polysaccharide vaccine Intramuscular-Lenvima
- Typhoid vi polysaccharide vaccine Intramuscular-Lenvima (14 MG Daily Dose)
- Typhoid vi polysaccharide vaccine Intramuscular-Lenvima (18 MG Daily Dose)
- Typhoid vi polysaccharide vaccine Intramuscular-Lenvima (20 MG Daily Dose)
- Typhoid vi polysaccharide vaccine Intramuscular-Lenvima (24 MG Daily Dose)
- Typhoid vi polysaccharide vaccine Intramuscular-Lenvima (8 MG Daily Dose)